Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 119   

Articles published

SHP 4,818.00 -5.50 (-0.11%)
price chart
Shire rises on the back of positive results from trial of swelling treatment
Shares in Shire Plc (LON:SHP, NASDAQ:SHPG) rose after it published positive results of a trial of a treatment for swelling under the skin (angioedema).
Shire's swelling disorder drug moves closer to US approval  Reuters
Shire's lanadelumab successful in late-stage HAE study; shares ahead 6 ...  Seeking Alpha
Shire reports better than expected first-quarter results boosted by its ...
Pharma group Shire Plc (LON:SHP) reported better than expected growth in first-quarter results at midday boosted by its acquisition last year of US haemophilia specialist Baxalta, and highlighted an advancing late-stage drugs pipeline.
Shire PLC (SHP): Delivers Strong, Broad Based Growth in Q1, Reiterates Full ...  Simply Wall St
Shire plc (SHPG) Tops Q1 EPS by 34c, Sales In-Line
Shire Plc (SHPG) Q1 2017 Results - Earnings Call Transcript
Q1 showed high growth across the portfolio, which, coupled with effective resource management, led to robust EPS growth. These results underscore that, for Shire, 2017 is all about growth, improving efficiency and paying down our debt. I'm pleased to ...
Shire plc (SHPG) to Offer New Research Into Chronic Hypoparathyroidism at the ...
Shire plc (NASDAQ: SHPG), the global leader in rare diseases, announced today new research to be presented on rhPTH(1-84) and on the treatment and management of chronic hypoparathyroidism at the upcoming 19th Annual Meeting of the European ...
Shire and tiny Lexington biotech say hemophilia drug trial misses mark
Shares of Xenetic Biosciences sank on Monday after the Lexington biotech announced a significant setback in its collaboration with Shire plc on a hemophilia drug. Xenetic (Nasdaq: XBIO), which has seven employees, announced disappointing results from a ...
It's Time To Buy Shire
The corporate signals from the Q1 2017 results have been positive, despite it's worth noting that the results was helped by some favorable one-offs effects.
Shire PLC (SHP) Rating Lowered to Reduce at HSBC Holdings plc
Shire PLC logo Shire PLC (LON:SHP) was downgraded by HSBC Holdings plc to a “reduce” rating in a note issued to investors on Friday.
Barclays PLC Reaffirms Overweight Rating for Shire PLC (SHP)  Sports Perspectives
HSBC Has Decided To Downgrade Shire PLC (LON:SHP) Shares  AppsforPCdaily
Earnings Growth Research: Enel Americas S.A. (ENIA), Shire plc (SHPG)
Shares of Enel Americas S.A. (NYSE:ENIA) are on a recovery track as they have regained 24% since bottoming out at $7.5 on Jun. 01, 2016.
How Analysts Feel About Shire PLC (ADR) (NASDAQ:SHPG)?
Among 19 analysts covering Shire plc (ADR) (NASDAQ:SHPG), 16 have Buy rating, 0 Sell and 3 Hold. Therefore 84% are positive.
Shire PLC (SHPG) Issues Earnings Results  The Cerbat Gem
The Shire PLC (SHPG) Given New $214.00 Price Target at Goldman Sachs Group Inc  BangaloreWeekly
Shire: Post-Earnings Analysis
Shire PLC (NASDAQ:SHPG) last posted its earnings for Q12017 on May 2nd. The company reported EPS $3.63 for the quarter, topping Street estimates of $3.29 by $0.34.